These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15133114)

  • 1. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes.
    Fujinaga Y; Inoue K; Watarai S; Sakaguchi Y; Arimitsu H; Lee JC; Jin Y; Matsumura T; Kabumoto Y; Watanabe T; Ohyama T; Nishikawa A; Oguma K
    Microbiology (Reading); 2004 May; 150(Pt 5):1529-1538. PubMed ID: 15133114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes.
    Fujinaga Y; Inoue K; Nomura T; Sasaki J; Marvaud JC; Popoff MR; Kozaki S; Oguma K
    FEBS Lett; 2000 Feb; 467(2-3):179-83. PubMed ID: 10675534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin.
    Lee JC; Yokota K; Arimitsu H; Hwang HJ; Sakaguchi Y; Cui J; Takeshi K; Watanabe T; Ohyama T; Oguma K
    Microbiology (Reading); 2005 Nov; 151(Pt 11):3739-3747. PubMed ID: 16272395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin.
    Nakamura T; Kotani M; Tonozuka T; Ide A; Oguma K; Nishikawa A
    J Mol Biol; 2009 Jan; 385(4):1193-206. PubMed ID: 19071137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular properties of each subcomponent in Clostridium botulinum type B haemagglutinin complex.
    Arimitsu H; Sakaguchi Y; Lee JC; Ochi S; Tsukamoto K; Yamamoto Y; Ma S; Tsuji T; Oguma K
    Microb Pathog; 2008 Aug; 45(2):142-9. PubMed ID: 18550324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1).
    Inoue K; Fujinaga Y; Honke K; Yokota K; Ikeda T; Ohyama T; Takeshi K; Watanabe T; Inoue K; Oguma K
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2533-2542. PubMed ID: 10517606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin.
    Mahmut N; Inoue K; Fujinaga Y; Hughes L; Arimitsu H; Sakaguchi Y; Ohtsuka A; Murakami T; Yokota K; Oguma K
    J Med Microbiol; 2002 Apr; 51(4):286-294. PubMed ID: 11926732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
    Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
    Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.
    Kouguchi H; Watanabe T; Sagane Y; Ohyama T
    Eur J Biochem; 2001 Jul; 268(14):4019-26. PubMed ID: 11453996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination.
    Sagane Y; Kouguchi H; Watanabe T; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    Biochem Biophys Res Commun; 2001 Nov; 288(3):650-7. PubMed ID: 11676492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization and preliminary X-ray analysis of the HA3 component of Clostridium botulinum type C progenitor toxin.
    Nakamura T; Tonozuka T; Kotani M; Obata K; Oguma K; Nishikawa A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Dec; 63(Pt 12):1038-40. PubMed ID: 18084087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar-binding sites of the HA1 subcomponent of Clostridium botulinum type C progenitor toxin.
    Nakamura T; Tonozuka T; Ide A; Yuzawa T; Oguma K; Nishikawa A
    J Mol Biol; 2008 Feb; 376(3):854-67. PubMed ID: 18178224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium botulinum type A haemagglutinin-positive progenitor toxin (HA(+)-PTX) binds to oligosaccharides containing Gal beta1-4GlcNAc through one subcomponent of haemagglutinin (HA1).
    Inoue K; Fujinaga Y; Honke K; Arimitsu H; Mahmut N; Sakaguchi Y; Ohyama T; Watanabe T; Inoue K; Oguma K
    Microbiology (Reading); 2001 Apr; 147(Pt 4):811-819. PubMed ID: 11283277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16.
    Ohyama T; Watanabe T; Fujinaga Y; Inoue K; Sunagawa H; Fujii N; Inoue K; Oguma K
    Microbiol Immunol; 1995; 39(7):457-65. PubMed ID: 8569530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex.
    Miyata K; Suzuki T; Hayashi S; Miyashita S; Ohyama T; Niwa K; Watanabe T; Sagane Y
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26223883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalency effects of hemagglutinin component of type B botulinum neurotoxin complex on epithelial barrier disruption.
    Amatsu S; Matsumura T; Yutani M; Fujinaga Y
    Microbiol Immunol; 2018 Feb; 62(2):80-89. PubMed ID: 29266585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain Yoichi.
    Matsuo T; Miyata K; Inui K; Ito H; Horiuchi R; Suzuki T; Yoneyama T; Oguma K; Niwa K; Watanabe T; Ohyama T
    FEMS Immunol Med Microbiol; 2011 Oct; 63(1):35-43. PubMed ID: 21635567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.
    Amatsu S; Sugawara Y; Matsumura T; Kitadokoro K; Fujinaga Y
    J Biol Chem; 2013 Dec; 288(49):35617-25. PubMed ID: 24165130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3.
    Sugawara Y; Iwamori M; Matsumura T; Yutani M; Amatsu S; Fujinaga Y
    FEBS J; 2015 Sep; 282(17):3334-47. PubMed ID: 26077172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization.
    Fujinaga Y; Inoue K; Shimazaki S; Tomochika K; Tsuzuki K; Fujii N; Watanabe T; Ohyama T; Takeshi K; Inoue K
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1291-8. PubMed ID: 7802661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.